Creo Medical Group PLC (CREO) — Strategic Asset Allocation Index
Creo Medical Group PLC (CREO) has a Strategic Asset Allocation Index of 14.1% as of June 2023. Strategic assets (PP&E of GBX9.70 Million plus long-term investments of GBX-) total GBX9.70 Million, measured against net assets of GBX69.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Creo Medical Group PLC Strategic Asset Allocation Index (2007–2021)
This chart shows how Creo Medical Group PLC's Strategic Asset Allocation Index has evolved across 12 annual periods from 2007 to 2021. As of June 2023, the index stands at 14.1%, representing strategic assets of GBX9.70 Million against net assets of GBX69.00 Million GBX. Explore cash flow conversion of Creo Medical Group PLC to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Creo Medical Group PLC (2007–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Creo Medical Group PLC from 2007 to 2021, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Creo Medical Group PLC market capitalisation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 11.7% | GBX8.60 Million | GBX8.60 Million | GBX- | GBX73.32 Million | ▲ +6.4 pp |
| 2020 | 5.4% | GBX3.38 Million | GBX3.38 Million | GBX- | GBX62.81 Million | ▲ +3.8 pp |
| 2019 | 1.6% | GBX1.30 Million | GBX1.30 Million | GBX- | GBX82.66 Million | ▼ -0.3 pp |
| 2018 | 1.9% | GBX906.26K | GBX906.26K | GBX- | GBX47.71 Million | ▼ -9.7 pp |
| 2018 | 11.6% | GBX853.00K | GBX853.00K | GBX- | GBX7.33 Million | ▲ +9.4 pp |
| 2017 | 2.2% | GBX325.02K | GBX325.02K | GBX- | GBX14.65 Million | ▼ -12.5 pp |
| 2016 | 14.7% | GBX239.75K | GBX239.75K | GBX- | GBX1.63 Million | ▲ +8.5 pp |
| 2016 | 6.2% | GBX199.36K | GBX199.36K | GBX- | GBX3.22 Million | ▼ -10.6 pp |
| 2015 | 16.8% | GBX126.00K | GBX126.00K | GBX- | GBX748.41K | ▲ +6.7 pp |
| 2014 | 10.1% | GBX139.00K | GBX139.00K | GBX- | GBX1.37 Million | ▲ +5.7 pp |
| 2008 | 4.4% | GBX5.00K | GBX5.00K | GBX- | GBX113.00K | ▼ -45.6 pp |
| 2007 | 50.0% | GBX6.00K | GBX6.00K | GBX- | GBX12.00K | — |